Iconoclastic Alzheimer’s Researcher Robert Moir Dies

The 58-year-old was best known for uncovering evidence of a link between pathogens and the neurodegenerative disease.

Written byShawna Williams
| 2 min read
Robert Moir

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: MASSACHUSETTS GENERAL HOSPITAL

Robert Moir, a researcher at Massachusetts General Hospital and Harvard University who challenged a longstanding hypothesis about the cause of Alzheimer’s disease, died of glioblastoma on December 20. He was 58.

Moir was born on April 2, 1961, and grew up on a farm in Western Australia, according to The New York Times. He didn’t learn to read and write until he was almost 12, but would later earn a PhD at the University of Melbourne, training with renowned Alzheimer’s researcher Colin Masters. “Rob was always a dogged researcher, meaning like a dog with its bone,” Masters told STAT in a 2018 interview. “He never gives up and has never been one to follow the standard line.”

Moir started a postdoc with Mass Gen’s Rudolph Tanzi in 1994, according to STAT, and later joined the faculty. In 2005, Moir and Tanzi discovered a natural antibody against ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies